The stock of Ajanta Pharma has reached near its downward sloping trendline resistance formed by connecting swing highs from October 2016, on the weekly time frame.

Markets plunge on negative global cues. Metals, Media and Auto stocks act as the biggest draggers. Index heavyweights like HDFC, Reliance and L&T pull down the benchmark index BSE Sensex by 377.81 points, on Thursday.

Better demand scenario and drop in raw material prices are likely to help companies from this sector to post better numbers in Q3FY19.

The construction business segment of Larsen & Toubro has secured an order totaling up to Rs. 1,060 crore.

The year 2018 has ended and the new year has begun. So let’s turn back and look at the mutual fund categories which performed well in the year 2018.

Following stocks are close to their 52-week low as at 12.54 p.m. on January 3, 2019.

The markets on January 03, 2019 opened up. BSE Sensex is trading at 35,662.24, down by 229.28 points and the Nifty is trading at 10,711.05, down by 81.45 points. 

The integrated pharma R&D company has received USFDA nod for pramipexole dihydrochloride extended-release tablets in various dosages.

Overall volumes in futures & options currently stand at 1.96 crore contracts with a turnover of Rs. 11,39,551.71 crore.

Bank of Baroda's board has approved the three-way merger with share swap ratio that marginally positive to the bank. The Central Cabinet approved the first-ever three bank merger deal, with this Vijaya Bank and Dena Bank will merger into Bank of Baroda (BoB).